Kura Oncology Inc

Healthcare · Biotechnology

10.70$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Kura Oncology Inc (KURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 67 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement KURA
Line item	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54	67
Cost of Revenue	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	0.2	0.6	0.8	0.8	0.8	0.1
Gross Profit	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	-0.2	-0.6	-0.8	-0.8	54	67
Research & Development	–	–	–	–	–	–	8.0	18	20	26	47	48	60	85	93	115	170	251
Selling, General & Administrative	–	0.0	0.0	0.0	0.0	0.0	3.8	6.1	8.0	9.7	16	20	31	47	47	51	77	120
Total Operating Expenses	0.0	0.0	0.0	0.0	0.0	0.0	11	24	28	36	63	67	92	131	140	165	247	371
Operating Income	0.0	0.0	0.0	0.0	0.0	0.0	-12	-24	-28	-36	-63	-67	-92	-131	-140	-166	-193	-304
Interest Expense	–	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.9	1.0	0.6	0.6	0.4	0.2	1.5	1.6	1.5
Pre-Tax Income	0.0	0.0	0.0	0.0	0.0	0.0	-11	-23	-28	-35	-60	-63	-90	-130	-136	-153	-172	-278
Income Tax Expense	–	–	–	–	–	–	0.3	0.0	0.0	0.0	3.4	-4.9	-0.2	-0.6	0.2	–	2.0	0.3
Net Income	0.0	0.0	0.0	0.0	0.0	0.0	-11	-23	-28	-35	-60	-63	-90	-130	-136	-153	-174	-279
EBITDA	0.0	0.0	0.0	0.0	0.0	0.0	-12	-24	-28	-36	-63	-67	-89	-129	-135	-150	-169	-276

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings